Silymarin, an antioxidant flavonoid, protects the liver from the toxicity of the anticancer drug paclitaxel

药理学 谷胱甘肽 生物 紫杉醇 丙二醛 肝细胞 丙氨酸转氨酶 毒性 细胞凋亡 抗氧化剂 水飞蓟宾 肝癌 脂肪变性 内科学 内分泌学 癌症 生物化学 医学 体外 遗传学
作者
Fatih Mehmet Gür,Sedat Bilğiç
出处
期刊:Tissue & Cell [Elsevier]
卷期号:83: 102158-102158 被引量:4
标识
DOI:10.1016/j.tice.2023.102158
摘要

One of the biggest factors that negatively affect the cancer treatment plan is the toxic effects of chemotherapeutics on non-target cells and tissues. This information prompted us to investigate the protective effects of silymarin (SL), a hepatoprotective agent, against the hepatotoxic effects of the anticancer drug paclitaxel (PAC). Four groups were formed from 28 rats as control, PAC (2 mg/kg), SL (100 mg/kg) and PAC + SL (combination of PAC with SL). After completing the experimental procedures, the tissues collected after anesthesia were analyzed by Western blot, qRT-PCR, biochemical, stereological, immunohistochemical, and histopathological techniques. Administration of PAC significantly increased the expression of tumor necrosis factor-alpha (TNF-α), Bax, cytochrome-c (cyt-c), and active caspase-3, as well as malondialdehyde (MDA) levels in liver tissue and decreased glutathione (GSH) levels compared with the control group. PAC also resulted in a significant increase in serum triglyceride (TG), cholesterol (CH), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels compared with the control group. Pathological changes such as microvesicular steatosis, the formation of Councilman bodies, an increase in total sinusoidal volume, and a decrease in the total number of hepatocytes were observed in the liver tissue of the PAC group. Almost all analysis results in the PAC + SL group were similar to those in the control group, and no significant pathological alterations were observed in this group. The data obtained show that SL protects the liver from the harmful effects of PAC, especially thanks to its TNF-α suppressor, anti-inflammatory, anti-apoptotic and antioxidant effects. Based on this result, in cases where PAC is used in cancer treatment, it can be recommended to be used together with SL to prevent harmful effects on healthy liver tissue and to continue treatment uninterruptedly and effectively.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hzl发布了新的文献求助10
刚刚
慕青应助DE2022采纳,获得10
1秒前
xuzj完成签到 ,获得积分10
2秒前
4秒前
6秒前
上帝178发布了新的文献求助10
8秒前
12chow chow完成签到 ,获得积分10
9秒前
11秒前
勤恳马里奥应助Vincent采纳,获得10
11秒前
Nancy0818发布了新的文献求助10
11秒前
大模型应助ccc采纳,获得10
12秒前
jacob完成签到,获得积分10
13秒前
13秒前
14秒前
彭于晏应助学术小张采纳,获得10
15秒前
19秒前
19秒前
21秒前
自由凌雪完成签到 ,获得积分10
23秒前
汉堡包应助科研通管家采纳,获得10
24秒前
爆米花应助ZhongxuanHa采纳,获得10
24秒前
majm发布了新的文献求助10
24秒前
大模型应助科研通管家采纳,获得10
24秒前
天天快乐应助科研通管家采纳,获得10
24秒前
隐形曼青应助科研通管家采纳,获得30
24秒前
打打应助科研通管家采纳,获得10
24秒前
斯文败类应助科研通管家采纳,获得10
24秒前
脑洞疼应助科研通管家采纳,获得10
24秒前
orixero应助科研通管家采纳,获得10
24秒前
小蘑菇应助科研通管家采纳,获得10
24秒前
SCQ应助科研通管家采纳,获得50
24秒前
SOLOMON应助科研通管家采纳,获得10
24秒前
SOLOMON应助科研通管家采纳,获得10
24秒前
24秒前
hhhh应助科研通管家采纳,获得10
24秒前
24秒前
隐形白开水完成签到,获得积分10
25秒前
年轻问夏发布了新的文献求助10
26秒前
27秒前
烟花应助覆覆盆子采纳,获得10
28秒前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
The Three Stars Each: The Astrolabes and Related Texts 900
Multifunctional Agriculture, A New Paradigm for European Agriculture and Rural Development 600
Bernd Ziesemer - Maos deutscher Topagent: Wie China die Bundesrepublik eroberte 500
A radiographic standard of reference for the growing knee 400
Glossary of Geology 400
Additive Manufacturing Design and Applications 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2476092
求助须知:如何正确求助?哪些是违规求助? 2140468
关于积分的说明 5455077
捐赠科研通 1863811
什么是DOI,文献DOI怎么找? 926556
版权声明 562846
科研通“疑难数据库(出版商)”最低求助积分说明 495755